Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Shanghai Pharmaceuticals Holding Co Ltd    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO LTD (601607)
My previous session
Most popular
  Report  
End-of-day quote. End-of-day quote  - 09/21
20.11 CNY   +1.67%
07/16SHANGHAI PHARMA : Ex-dividend day for final dividend
FA
05/10SHANGHAI PHARMA : ·Reply Slip
PU
05/10SHANGHAI PHARMA : ·Proxy forms
PU
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

Shanghai Pharmaceuticals : to Buy Cardinal Health's Unit for US$557 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/15/2017 | 02:16am CEST
   By Joanne Chiu 
 

Shanghai Pharmaceuticals Holding Co. (2607.HK) plans to buy the pharmaceutical distribution network of U.S. company Cardinal Health Inc. in Hong Kong and mainland China for US$557 million.

The Hong Kong listed pharmaceutical company said Wednesday that it has agreed to buy the entire interest in Cardinal Health's unit -Cardinal Health (L) Co. in a bid to broaden the coverage of its distribution network in China and build up direct-to-pharmacy chain with specialty brands.

Cardinal Health (L) Co. operates 14 direct sales companies and 17 distribution and operation centres in China with a total storage area of around 146,000 square meters and around 7,000 square meters cold storage capacity, it said.

Write to Joanne Chiu at joanne.chiu@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
CARDINAL HEALTH -0.42% 54.94 Delayed Quote.-9.96%
SHANGHAI PHARMACEUTICALS HOLDING CO LTD 1.67% 20.11 End-of-day quote.-16.87%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHANGHAI PHARMACEUTICALS H
07/16SHANGHAI PHARMACEUTICALS HOLDING CO : Ex-dividend day for final dividend
FA
05/21SHANGHAI PHARMACEUTICALS : SH Pharma to add 26.34% stake in Techpool Bio-pharma
AQ
05/10SHANGHAI PHARMACEUTICALS : ·Reply Slip
PU
05/10SHANGHAI PHARMACEUTICALS : ·Proxy forms
PU
05/10SHANGHAI PHARMACEUTICALS : ·Circulars
PU
05/10SHANGHAI PHARMACEUTICALS : ·Notice Of Annual General Meeting
PU
05/10SHANGHAI PHARMACEUTICALS : ·Notification Letter & Request Form(Registered..
PU
05/10SHANGHAI PHARMACEUTICALS : ·Notification Letter & Request Form(Non-regist..
PU
05/02SHANGHAI PHARMACEUTICALS : ·Monthly Return of Equity Issuer on Movements in Secu..
PU
04/20Generics group Alvogen puts Eastern European operations up for sale - sources
RE
More news
News from SeekingAlpha
2017Cardinal Health sells China business for $1.2B 
2017WEEK IN REVIEW : Vivace Details Its Capital Efficient Plan To Develop Novel Canc.. 
2015WEEK IN REVIEW : Hepalink Pharma Buys U.S.-Based CMO Cytovance 
2015WEEK IN REVIEW : Porton Fine Chemicals Buys Dongbang Pharma 
Financials (CNY)
Sales 2018 160 B
EBIT 2018 5 926 M
Net income 2018 4 062 M
Debt 2018 6 713 M
Yield 2018 2,03%
P/E ratio 2018 14,27
P/E ratio 2019 12,58
EV / Sales 2018 0,38x
EV / Sales 2019 0,33x
Capitalization 54 332 M
Chart SHANGHAI PHARMACEUTICALS HOLDING CO LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 25,7  CNY
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
Da Wei Liu Deputy Chief Executive Officer & Secretary
Min Zuo President & Executive Director
Jun Zhou Chairman
Bo Shen Chief Financial Officer, Executive Director & VP
Xin Chen Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-16.87%7 810
SINOPHARM HOLDING CO LTD12.80%13 343
TSURUHA HOLDINGS INC.-11.52%5 841
COSMOS PHARMACEUTICAL CORP6.76%4 406
SUNDRUG CO LTD-23.72%4 168
SUGI HOLDINGS CO.,LTD.-2.77%3 116